U Lueken1, B Straube2, I Reinhardt3, N I Maslowski1, H-U Wittchen1, A Ströhle4, A Wittmann4, B Pfleiderer5, C Konrad2, A Ewert5, C Uhlmann6, V Arolt6, A Jansen2, T Kircher2. 1. Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Germany. 2. Department of Psychiatry and Psychotherapy, Philipps University Marburg, Germany. 3. Department of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University, Germany. 4. Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Germany. 5. Department of Clinical Radiology, University of Münster, Germany. 6. Department of Psychiatry and Psychotherapy, University of Münster, Germany.
Abstract
BACKGROUND: Although several neurophysiological models have been proposed for panic disorder with agoraphobia (PD/AG), there is limited evidence from functional magnetic resonance imaging (fMRI) studies on key neural networks in PD/AG. Fear conditioning has been proposed to represent a central pathway for the development and maintenance of this disorder; however, its neural substrates remain elusive. The present study aimed to investigate the neural correlates of fear conditioning in PD/AG patients. METHOD: The blood oxygen level-dependent (BOLD) response was measured using fMRI during a fear conditioning task. Indicators of differential conditioning, simple conditioning and safety signal processing were investigated in 60 PD/AG patients and 60 matched healthy controls. RESULTS: Differential conditioning was associated with enhanced activation of the bilateral dorsal inferior frontal gyrus (IFG) whereas simple conditioning and safety signal processing were related to increased midbrain activation in PD/AG patients versus controls. Anxiety sensitivity was associated positively with the magnitude of midbrain activation. CONCLUSIONS: The results suggest changes in top-down and bottom-up processes during fear conditioning in PD/AG that can be interpreted within a neural framework of defensive reactions mediating threat through distal (forebrain) versus proximal (midbrain) brain structures. Evidence is accumulating that this network plays a key role in the aetiopathogenesis of panic disorder.
RCT Entities:
BACKGROUND: Although several neurophysiological models have been proposed for panic disorder with agoraphobia (PD/AG), there is limited evidence from functional magnetic resonance imaging (fMRI) studies on key neural networks in PD/AG. Fear conditioning has been proposed to represent a central pathway for the development and maintenance of this disorder; however, its neural substrates remain elusive. The present study aimed to investigate the neural correlates of fear conditioning in PD/AG patients. METHOD: The blood oxygen level-dependent (BOLD) response was measured using fMRI during a fear conditioning task. Indicators of differential conditioning, simple conditioning and safety signal processing were investigated in 60 PD/AG patients and 60 matched healthy controls. RESULTS: Differential conditioning was associated with enhanced activation of the bilateral dorsal inferior frontal gyrus (IFG) whereas simple conditioning and safety signal processing were related to increased midbrain activation in PD/AG patients versus controls. Anxiety sensitivity was associated positively with the magnitude of midbrain activation. CONCLUSIONS: The results suggest changes in top-down and bottom-up processes during fear conditioning in PD/AG that can be interpreted within a neural framework of defensive reactions mediating threat through distal (forebrain) versus proximal (midbrain) brain structures. Evidence is accumulating that this network plays a key role in the aetiopathogenesis of panic disorder.
Authors: Ben J Harrison; Miquel A Fullana; Carles Soriano-Mas; Esther Via; Jesus Pujol; Ignacio Martínez-Zalacaín; Daniella Tinoco-Gonzalez; Christopher G Davey; Marina López-Solà; Victor Pérez Sola; José M Menchón; Narcís Cardoner Journal: Hum Brain Mapp Date: 2015-07-06 Impact factor: 5.038
Authors: H Weber; J Richter; B Straube; U Lueken; K Domschke; C Schartner; B Klauke; C Baumann; C Pané-Farré; C P Jacob; C-J Scholz; P Zwanzger; T Lang; L Fehm; A Jansen; C Konrad; T Fydrich; A Wittmann; B Pfleiderer; A Ströhle; A L Gerlach; G W Alpers; V Arolt; P Pauli; H-U Wittchen; L Kent; A Hamm; T Kircher; J Deckert; A Reif Journal: Mol Psychiatry Date: 2015-09-01 Impact factor: 15.992
Authors: Katherine S Young; Susan Y Bookheimer; Robin Nusslock; Richard E Zinbarg; Katherine S F Damme; Iris Ka-Yi Chat; Nicholas J Kelley; Meghan Vinograd; Marcelina Perez; Kelly Chen; Aileen Echiverri Cohen; Michelle G Craske Journal: Neuropsychopharmacology Date: 2021-04-08 Impact factor: 8.294
Authors: Borah Kim; Jeong Hoon Kim; Min-Kyoung Kim; Kang Soo Lee; Youngki Kim; Tai Kiu Choi; Yun Tai Kim; Sang-Hyuk Lee Journal: PLoS One Date: 2014-04-30 Impact factor: 3.240
Authors: B Straube; A Reif; J Richter; U Lueken; H Weber; V Arolt; A Jansen; P Zwanzger; K Domschke; P Pauli; C Konrad; A L Gerlach; T Lang; T Fydrich; G W Alpers; A Ströhle; A Wittmann; B Pfleiderer; H-U Wittchen; A Hamm; J Deckert; T Kircher Journal: Transl Psychiatry Date: 2014-12-16 Impact factor: 6.222
Authors: Gloria-Beatrice Wintermann; Markus Donix; Peter Joraschky; Johannes Gerber; Katja Petrowski Journal: PLoS One Date: 2013-09-24 Impact factor: 3.240